Autosomal dominant polycystic kidney disease: emerging concepts of pathogenesis and new treatments.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMID 19188475)

Published in Cleve Clin J Med on February 01, 2009

Authors

William E Braun1

Author Affiliations

1: Department of Nephrology and Hypertension, Transplantation Center, Glickman Urological and Kidney Institute, Q7, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

Articles citing this

Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR. PLoS One (2010) 1.05

A novel long-range PCR sequencing method for genetic analysis of the entire PKD1 gene. J Mol Diagn (2012) 0.95

Molecular diagnosis of autosomal dominant polycystic kidney disease using next-generation sequencing. J Mol Diagn (2013) 0.90

Heart-kidney interaction: epidemiology of cardiorenal syndromes. Int J Nephrol (2010) 0.82

Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective. Int J Nephrol Urol (2010) 0.82

ADPKD: Prototype of Cardiorenal Syndrome Type 4. Int J Nephrol (2010) 0.81

Common and uncommon bilateral adult renal masses. Cancer Imaging (2012) 0.78

Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease. Sci Rep (2015) 0.76

An unusual association of autosomal polycystic kidney disease and multiple myeloma. BMJ Case Rep (2014) 0.75

Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease. Medicine (Baltimore) (2016) 0.75

System analysis of gene mutations and clinical phenotype in Chinese patients with autosomal-dominant polycystic kidney disease. Sci Rep (2016) 0.75

Elective cesarean delivery in non-dialyzed parturient with chronic renal failure. J Anaesthesiol Clin Pharmacol (2013) 0.75

Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation. Stem Cell Res Ther (2017) 0.75